Your browser doesn't support javascript.
loading
Safety and Efficacy Results From iSABR, a Phase 1 Study of Stereotactic ABlative Radiotherapy in Combination With Durvalumab for Early-Stage Medically Inoperable Non-Small Cell Lung Cancer.
Wu, Trudy C; Stube, Annalise; Felix, Carol; Oseguera, Denise; Romero, Tahmineh; Goldman, Jonathan; Garon, Edward B; Lee, Jay M; Glaspy, John; Lisberg, Aaron E; Rusthoven, Chad G; Camidge, D Ross; Siva, Shankar; Solomon, Benjamin; Lee, Alan; Tenn, Stephen E; Shaverdian, Narek; Steinberg, Michael L; Raldow, Ann C; Lee, Percy.
Affiliation
  • Wu TC; Department of Radiation Oncology, University of California, Los Angeles, California.
  • Stube A; Department of Radiation Oncology, University of California, Los Angeles, California.
  • Felix C; Department of Radiation Oncology, University of California, Los Angeles, California.
  • Oseguera D; Department of Medicine, Division of Hematology and Oncology, University of California, Los Angeles, California.
  • Romero T; Department of Medicine, University of California, Los Angeles, California.
  • Goldman J; Department of Medicine, Division of Hematology and Oncology, University of California, Los Angeles, California.
  • Garon EB; Department of Medicine, Division of Hematology and Oncology, University of California, Los Angeles, California.
  • Lee JM; Department of Surgery, Division of Thoracic Surgery, University of California, Los Angeles, California.
  • Glaspy J; Department of Medicine, Division of Hematology and Oncology, University of California, Los Angeles, California.
  • Lisberg AE; Department of Medicine, Division of Hematology and Oncology, University of California, Los Angeles, California.
  • Rusthoven CG; Department of Radiation Oncology, University of Colorado School of Medicine, Aurora, Colorado.
  • Camidge DR; Department of Medical Oncology, University of Colorado School of Medicine, Aurora, Colorado.
  • Siva S; Department of Radiation Oncology, Peter MacCallum Cancer Centre and Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia.
  • Solomon B; Department of Medical Oncology, Peter MacCallum Cancer Centre and Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne, Victoria, Australia.
  • Lee A; Department of Radiation Oncology, University of California, Los Angeles, California.
  • Tenn SE; Department of Radiation Oncology, University of California, Los Angeles, California.
  • Shaverdian N; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York.
  • Steinberg ML; Department of Radiation Oncology, University of California, Los Angeles, California.
  • Raldow AC; Department of Radiation Oncology, University of California, Los Angeles, California.
  • Lee P; Department of Radiation Oncology, City of Hope, Los Angeles, California. Electronic address: PercyLee@coh.org.
Int J Radiat Oncol Biol Phys ; 117(1): 118-122, 2023 09 01.
Article in En | MEDLINE | ID: mdl-37023987
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Radiosurgery / Carcinoma, Non-Small-Cell Lung / Lung Neoplasms Type of study: Clinical_trials / Guideline Limits: Humans Language: En Journal: Int J Radiat Oncol Biol Phys Year: 2023 Document type: Article
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Radiosurgery / Carcinoma, Non-Small-Cell Lung / Lung Neoplasms Type of study: Clinical_trials / Guideline Limits: Humans Language: En Journal: Int J Radiat Oncol Biol Phys Year: 2023 Document type: Article